GPT and metabolic dysfunction-associated steatohepatitis: The elevated baseline aminotransferases of its participants, indicative of NASH, make the evaluation of ALT and AST as treatment outcomes complicated, and partially explains why the MD of ALT is an outlier compared with the results of the rest of the included studies.